The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...
The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...
Results published in the American Journal of Sports Medicine showed surgical delays of more than 4 months may increase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback